Cargando…
PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates
We argue that the COVID-19 pandemic will result in increased antimicrobial resistance (AMR). Broad-spectrum antibiotic use is common among hospitalized COVID-19 patients and in excess of reported secondary infection rates, suggesting unnecessary prescribing. Selection pressure is likely to be partic...
Autores principales: | Clancy, Cornelius J, Buehrle, Deanna J, Nguyen, M Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454644/ https://www.ncbi.nlm.nih.gov/pubmed/34192248 http://dx.doi.org/10.1093/jacamr/dlaa049 |
Ejemplares similares
-
Trends in Outpatient Antibiotic Prescriptions in the United States During the COVID-19 Pandemic in 2020
por: Buehrle, Deanna J., et al.
Publicado: (2021) -
CON: COVID-19 will not result in increased antimicrobial resistance prevalence
por: Collignon, Peter, et al.
Publicado: (2020) -
524. Understanding the Treatment of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections in the United States (US): Insights from a Survey of Hospital-Based Pharmacists
por: Potoski, Brian, et al.
Publicado: (2019) -
Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
por: Buehrle, Deanna J, et al.
Publicado: (2020) -
1529. Suprapubic Catheter Placement Improves Antimicrobial Stewardship in a Veterans Affairs Long-term Care Facility
por: Buehrle, Deanna J, et al.
Publicado: (2018)